News Daily News Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis L.A. McKeown February 06, 2026
News Daily News Year in Review: Pulsed-Field Ablation Again Tops Heart Rhythm News Todd Neale December 24, 2025
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Daily News Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI L.A. McKeown October 09, 2025
News Daily News ACC: It’s Time for Clinicians to Address Inflammation in CVD Caitlin E. Cox October 03, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves Caitlin E. Cox August 26, 2025
News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News Frail Older Patients With AF May Fare Better Switching to DOAC Todd Neale August 05, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair Todd Neale July 31, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025
News Daily News Stress Testing Picks Up ‘Novel Risk Patterns’ in Stable CAD Patients: ISCHEMIA Caitlin E. Cox July 10, 2025
News Daily News ‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use Yael L. Maxwell June 18, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year Todd Neale April 11, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025